Zagros Pharmed Pars Pharmaceutical Company (DEDAM) cash flow statement
Operating, investing and financing cash flows, and the closing balance
- Ticker
- DEDAM
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/03/31 | To 1404/03/31 | To 1403/03/31 | To 1402/03/31 | To 1401/03/31 | To 1400/03/31 |
|---|---|---|---|---|---|---|
| Cash generated from operations | -160,729 | -253,322 | 142,549 | 516,728 | 91,649 | 145,106 |
| Cash payments for income tax | -80,000 | -60,000 | 0 | -49,472 | -3,572 | -20,000 |
| Net cash inflow (outflow) from operating activities | -240,729 | -313,322 | 142,549 | 467,256 | 88,077 | 125,106 |
| Cash payments for purchase of property, plant and equipment | -610 | 0 | -459 | -2,579 | -2,536 | -3,630 |
| Cash receipts from dividends | 2,047 | 0 | 0 | 18 | 0 | 0 |
| Net cash inflow (outflow) from investing activities | 1,437 | 1,744 | -9,937 | -5,058 | -5,601 | -3,382 |
| Net cash inflow (outflow) before financing activities | -239,292 | -311,578 | 132,612 | 462,198 | 82,476 | 121,724 |
| Cash receipts from sale of treasury shares | 71,386 | 0 | 0 | 0 | 0 | 0 |
| Cash payments for purchase of treasury shares | -15,325 | 0 | 0 | 0 | 0 | 0 |
| Cash receipts from facilities | 854,845 | 713,919 | 373,675 | 0 | 168,646 | 235,370 |
| Cash payments for principal of loans | -573,222 | -599,086 | -279,357 | -158,092 | -156,209 | -326,963 |
| Cash payments for interest on loans | -44,202 | -79,586 | -97,592 | -65,396 | -66,284 | -27,260 |
| Net cash inflow (outflow) from financing activities | 293,482 | 35,247 | -3,274 | -225,428 | -54,847 | -118,853 |
| Net increase (decrease) in cash | 54,190 | -276,331 | 129,338 | 236,770 | 27,629 | 2,871 |
| Cash balance at beginning of year | 42,558 | 289,445 | 289,445 | 273,011 | 76,876 | 71,868 |
| Cash balance at end of year | 96,748 | 13,114 | 418,783 | 509,781 | 104,505 | 74,739 |
Reporting periods
77 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/03/31.